LecicarbonLogo500

Patient Info

Patient Information A fast acting suppository laxative, giving a predictable, natural response

A predictable response suits certain patients

bed  Bed Ridden:
Patient management in a predictable time frame
disabled  Mobility Compromised:
Take medication and receive effect in 1 lavatory visit
cross  Opioid Pain Management:
Relieve constipation caused by opioid use
food Nil by Mouth:
Alternative route of administration
  Bowel Preparation:
Use prior to diagnostic or therapeutic procedures in the rectum
Rectal Surgery:
Use before operations

Lecicarbon A Patient Information

This link will take you to the electronic Medicines Compendium (eMC) website.

Lecicarbon A Patient Information View PIL

Lecicarbon C Patient Information

This link will take you to the electronic Medicines Compendium (eMC) website.

Lecicarbon C Patient Information View PIL

 

For further information, please call: 01730 231148, email: info@aspirepharma.co.uk
or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon, please see the abbreviated prescribing information.
Revision reference – Lecicarbon_8_08/11/2018